Search Within

Navin Kumar Chintala

Formats
  1. Journal Article (13)
  2. Meeting Abstract (11)
  3. Review (3)
Groups
  1. Surgery (26)
  2. Sloan Kettering Institute Postdocs (21)
  3. Department of Medicine (11)
  4. Solid Tumor Oncology Division (10)
  5. Thoracic Oncology (10)
  6. Biostatistics Service (8)

More Groups

People
  1. Prasad Adusumilli (26)
  2. David Jones (9)
  3. Kay See Tan (8)
  4. Marjorie Zauderer (8)
  5. Xiaoyu Li (7)
  6. Jasmeen Saini (6)

More People

Years
  1. 2023 (6)
  2. 2022 (1)
  3. 2021 (4)
  4. 2020 (1)
  5. 2019 (4)
  6. 2018 (8)

More Years

Publications
  1. Journal of Thoracic Oncology (7)
  2. Cancer Research (2)
  3. Annals of Oncology (1)
  4. Annals of Translational Medicine (1)
  5. Cancer Cell (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. Elsevier Inc. (8)
  2. American Association for Cancer Research (4)
  3. Cell Press (2)
  4. Frontiers Media S.A. (2)
  5. Nature Publishing Group (2)
  6. AME Publishing Company (1)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity
    Review

    Kiesgen, S.; Messinger, J. C.; Chintala, N. K.; Tano, Z.; Adusumilli, P. S.
    Nature Protocols (2021)

    Fulltext@MSK | Save
  • Regional delivery of clinical-grade mesothelin-targeted CAR T cells with cell-intrinsic PD-1 checkpoint blockade: Translation to a phase I trial
    Meeting Abstract

    Kiesgen, S.; Linot, C.; Quach, H. T.; Saini, J.; Bellis, R.; Banerjee, S.; Hou, Z.; Chintala, N. K.; Sadelain, M.; Adusumilli, P. S.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors
    Review

    Grosser, R.; Cherkassky, L.; Chintala, N.; Adusumilli, P. S.
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Globular C1q receptor (gC1qR/p32/HABP1) is overexpressed in malignant pleural mesothelioma and is associated with increased survival in surgical patients treated with chemotherapy
    Journal Article

    Li, X.; Eguchi, T.; Aly, R. G.; Chintala, N. K.; Tan, K. S.; Zauderer, M. G.; Dembitzer, F. R.; Beasley, M. B.; Ghebrehiwet, B.; Adusumilli, P. S.; more...
    Frontiers in Oncology (2019)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • An ex-vivo patient-derived, immunocompetent (PDI) culture system to evaluate immunotherapeutic agents' anti-tumor efficacy
    Meeting Abstract

    Tano, Z.; Kiesgen, S.; Chintala, N.; Dozier, J.; Messinger, J.; Tan, K. S.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Comparative efficacy of T-cell intrinsic versus extrinsic PD-1 blockade to overcome PD-L1+ tumor-mediated exhaustion
    Meeting Abstract

    Dozier, J.; Chen, N.; Saini, J.; Chintala, N.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • gC1qR expression is independently prognostic for survival benefit following chemotherapy in mesothelioma
    Meeting Abstract

    Li, X.; Eguchi, T.; Aly, R.; Chintala, N.; Tan, K. S.; Messinger, J.; Zauderer, M.; Ghebrehiwet, B.; Adusumilli, P.; Peerschke, E.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Immune microenvironment and its association with adjuvant chemotherapy benefit in locoregionally advanced lung adenocarcinoma
    Meeting Abstract

    Vaghjiani, R.; Eguchi, T.; Chintala, N.; Li, X.; Aly, R.; Emoto, K.; Tan, K. S.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save